CAERI(SH:601965)2020-04-28 16:00Financial Performance - Net profit attributable to shareholders was ¥61,925,116.93, representing a decline of 34.43% year-on-year, primarily due to increased depreciation costs and higher R&D expenses [5]. - Operating revenue for the period was ¥491,546,152.71, down 1.91% year-on-year, with technical services and equipment business revenue increasing by 8.08% [5]. - Basic earnings per share were ¥0.06, down 40.00% compared to the previous year [5]. - Net profit for Q1 2020 was CNY 62,780,091.17, down 34.3% from CNY 95,423,530.60 in Q1 2019 [22]. - The company's operating profit for Q1 2020 was approximately ¥88.27 million, a decrease of 9.5% compared to ¥97.84 million in Q1 2019 [25]. - Net profit for Q1 2020 was approximately ¥72.74 million, down 12.5% from ¥83.24 million in Q1 2019 [25]. - Total operating revenue for Q1 2020 was CNY 491,546,152.71, a decrease of 1.1% from CNY 501,096,784.29 in Q1 2019 [21]. Cash Flow - The net cash flow from operating activities was -¥81,742,352.88, indicating a negative cash flow situation [4]. - Cash flow from operating activities showed a net outflow of approximately ¥81.74 million, compared to a net outflow of ¥70.63 million in Q1 2019 [28]. - Total cash inflow from operating activities was approximately ¥336.27 million, an increase from ¥315.82 million in Q1 2019 [27]. - Cash outflow for operating activities totaled approximately ¥418.01 million, up from ¥386.44 million in Q1 2019 [28]. - The company’s cash flow from financing activities showed a net inflow of approximately ¥9.15 million, down from ¥41.76 million in Q1 2019 [28]. - The company reported a cash inflow from financing activities of ¥22,074,666.61, contrasting with a cash outflow of ¥22,492,970.03 [31]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,059,022,443.36, a slight increase of 0.01% compared to the end of the previous year [4]. - Total liabilities decreased significantly, with a notable reduction in bank acceptance deposits from the previous year [13]. - Current liabilities decreased to ¥1,040 million from ¥1,159 million, indicating a reduction of approximately 10.2% [16]. - The total liabilities were reported at ¥1,212 million, down from ¥1,345 million, indicating a decrease of approximately 9.8% [17]. - The total current assets slightly increased to CNY 2,606,947,857.48 from CNY 2,604,618,725.28 [15]. - Total current assets reached RMB 1,949,649,945.57, reflecting a significant increase compared to previous periods [36]. Research and Development - The company increased its R&D investment, leading to a rise in R&D expenses compared to the previous year [5]. - R&D expenses rose by 47.56% to CNY 14,904,397.29 from CNY 10,100,728.18, indicating increased investment in technology and product development [11]. - Research and development expenses rose to CNY 14,904,397.29, an increase of 47.5% from CNY 10,100,728.18 in Q1 2019 [21]. Other Income and Expenses - Other income increased by 70.80% to CNY 11,710,989.38 from CNY 6,856,578.71, primarily due to increased government subsidies [11]. - The company reported a 4291.38% increase in other expenses to CNY 2,519,864.39, mainly due to donations related to COVID-19 [12]. Shareholder Information - The total number of shareholders at the end of the reporting period was 23,772 [7]. - Owner's equity increased to CNY 4,332,457,639.82, up from CNY 4,258,495,943.02 in the previous year [21]. - The total equity attributable to shareholders was ¥4,696,103,076.08, consistent with the previous reporting period [34]. Future Outlook - The company is focused on expanding its market presence and developing new products, although specific figures were not disclosed in the call [39]. - Future guidance indicates a commitment to maintaining financial stability while exploring growth opportunities in new technologies and markets [39].